Replies to post #334401 on Innovation Pharmaceuticals Inc (IPIX)

[WaileaGrandIAm]

As much as I agree with you with the anticipation of BRIL’s performance we will more than likely see an SOC of critical to severe patients coming from Cytodyn and Leronlimab.

https://www.cytodyn.com/newsroom/press-releases/detail/477/cytodyn-receives-positive-dsmc-recommendation-after-interim

I’m significantly invested in IPIX and want to see us prevail but not being in a human trial yet hasn’t helped our cause.

I wouldn’t be surprised to see the DSMC unblind the results of CYDY’s trial and the FDA approving Leronlimab as an SOC.

We all know that the FDA is pumping BP garbage in regards to EUA’s for therapeutics and we need to safe lives with legitimate medicine I.e. Leronlimab and Brilacidin eventually.

[loanranger]

"All the other current methods of treatment are only for none to mild symptoms"
Wrong again. Where did you read that?

"The emergency authorization for Regeneron’s drug is limited in scope: It is for people 12 and over who have tested positive for the coronavirus and who are at high risk for developing severe Covid-19. Evidence so far suggests that antibody treatments work best early in the course of the disease, before the virus has gained a foothold in the body. Like Eli Lilly’s treatment, Regeneron’s is not authorized for use in people who are hospitalized or who need oxygen."

Three wrongs do not make a right.



"IMO I cannot see how this is an apples to apples test since there is currently NO treatment/vaccine/antibody/etc that helps when SEVERE symptoms are being treated."
Who is making these tests/comparisons?